Literature DB >> 10868659

Liver transplantation improves cirrhosis-associated impaired oral glucose tolerance.

A Shetty1, S Wilson, P Kuo, J L Laurin, C D Howell, L Johnson, E M Allen.   

Abstract

BACKGROUND: Thirty-five percent to 80% of cirrhotic patients have impaired glucose tolerance (IGT) or diabetes mellitus (DM). Diabetic cirrhotics have higher morbidity and mortality than nondiabetics. Therefore, it would be worthwhile to determine whether liver transplantation improves glucose homeostasis in these patients.
METHOD: A total of 26 patients awaiting liver transplantation were evaluated for impaired glucose homeostasis by fasting blood glucose and/or oral glucose tolerance tests (OGTT). Five patients underwent transplant surgery within 1 year of OGTT and had a repeat OGTT 3-6 months after transplantation.
RESULTS: Sixty-five percent (17/26) of the patients had abnormal glucose homeostasis. Twenty-three percent (6/26) met American Diabetes Association criteria for DM, and another 42.3% (11/26) had IGT. All patients had normal HbA1C levels. After transplantation, the 2-hr blood glucose improved in four patients and the mean 2-hr glucose level was reduced (204 +/- 94 vs. 132 +/- 53 mg/dl [mean +/- SD, P=0.051]).
CONCLUSION: Liver transplantation can reverse cirrhosis-associated impaired glucose tolerance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10868659     DOI: 10.1097/00007890-200006150-00043

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Determination of glycated hemoglobin in patients with advanced liver disease.

Authors:  Theresa Lahousen; Karin Hegenbarth; Rottraut Ille; Rainer-W Lipp; Robert Krause; Randie-R Little; Wolfgang-J Schnedl
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

2.  Utility and Limitations of Glycated Hemoglobin (HbA1c) in Patients with Liver Cirrhosis as Compared with Oral Glucose Tolerance Test for Diagnosis of Diabetes.

Authors:  Tejasav Sehrawat; Anuraag Jindal; Paaras Kohli; Amit Thour; Jasbinder Kaur; Atul Sachdev; Yashdeep Gupta
Journal:  Diabetes Ther       Date:  2018-01-05       Impact factor: 2.945

Review 3.  Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives.

Authors:  Diego García-Compeán; Emanuela Orsi; Ramesh Kumar; Felix Gundling; Tsutomu Nishida; Jesús Zacarías Villarreal-Pérez; Ángel N Del Cueto-Aguilera; José A González-González; Giuseppe Pugliese
Journal:  World J Gastroenterol       Date:  2022-02-28       Impact factor: 5.742

Review 4.  Hepatogenous diabetes: Knowledge, evidence, and skepticism.

Authors:  Ramesh Kumar; Diego García-Compeán; Tanmoy Maji
Journal:  World J Hepatol       Date:  2022-07-27

5.  Hepatitis B Virus Infection and Increased Risk of Gestational Diabetes Regardless of Liver Function Status: A Xiamen Area Population-Based Study.

Authors:  Min Zhao; Shuyu Yang; Xiaojie Su; Tzu-Chieh Hung; Yishan Liu; Wenjie Zheng
Journal:  Front Physiol       Date:  2022-07-11       Impact factor: 4.755

Review 6.  Hepatogenous Diabetes: An Underestimated Problem of Liver Cirrhosis.

Authors:  Ramesh Kumar
Journal:  Indian J Endocrinol Metab       Date:  2018 Jul-Aug

7.  Outcomes of Combined Liver and Pancreas Transplantation: A Review of the SRTR National Database and a Report of the Largest Single Center Series.

Authors:  Cheukfai Li; Wei Zhang; Qiang Zhao; Maodong Ye; Weiqiang Ju; Linwei Wu; Yi Ma; Anbin Hu; Guodong Wang; Xiaofeng Zhu; Zhiyong Guo; Dongping Wang; Xiaoshun He
Journal:  Front Med (Lausanne)       Date:  2020-10-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.